Contact Lenses/Eye Wear News

Two eye care professionals have seen a spike in non-infectious focal corneal infiltrates associated with a leading contact lens solution.

CHICAGO – Researchers from Bausch + Lomb shared positive study results regarding the company’s new Biotrue ONEday lenses and multipurpose solution.

CHICAGO – Bausch + Lomb announced here at Optometry’s Meeting that its Biotrue ONEday contact lenses have received clearance from the U.S. Food and Drug Administration.

CHICAGO – Eye Solutions Inc., with partner Signet Armorlite, introduced its Blu-Tech lens technology that offers protection from ultraviolet and high energy visible light.

Clinicians should expect challenges associated with the development of drug elution via contact lenses, a speaker at the British Contact Lens Association Conference said.

Researchers found that using hyaluronic acid in silicone hydrogels to help control the release of hydrophobic drugs resulted in an increase in both the amount and the duration of the drug released.

When patients complain of comfort issues with contact lens wear, practitioners will first examine the ocular surface and evaluate the fit. Once those findings are found to be normal, clinicians should consider soaps and solutions.

A recent study found that correcting the on-axis refractive error in moderate to high myopia with conventional spectacle lenses resulted in hyperopic defocus in the peripheral retina, while correcting the same eyes with conventional soft contact lenses resulted in significant myopic defocus in the periphery.

Bausch + Lomb has received U.S. Food and Drug Administration approval for enVista, a hydrophobic acrylic IOL, according to a press release.

BIRMINGHAM, U.K. — Bausch + Lomb has unveiled a premium daily disposable contact lens designed to better mimic the biology of the eye, according to a press release.